Skip to main content

Table 1 Participant population characteristics at study entry

From: Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice

Characteristic SAD BDI All
  n = 64 n = 175 N = 239
Demographics    
Age, mean (range), years 39.6 (20–66) 42.6 (19–79) 41.8 (18–79)
Gender, women,%; 50.0%; 61.1%; 58.3%;
Clinical status    
Age at first symptoms of mental illness, median (range), years 18 (5–43) 17 (3–65) 17.5 (3–65)
CGI-BP-S overall score, mean (SD) 3.7 (1.2) 3.9 (1.4) 3.8 (1.3)
YMRS total score, median (range) 4.5 (0–39) 5.0 (0–45) 5.0 (0–45)
HAMD21 total score, mean (SD) 15.5 (8.4) 12.7 (8.5) 13.4 (8.6)*
At least 1 hospital admission; past 3 months,%; 35.9%; 32.0%; 33.1%;
Functional status    
EQ-5D health state score, mean (SD) 61.6 (22.7) 68.2 (18.8) 66.4 (20.1)*
Daily smoker,%; 56.3%; 49.1%; 51.0%;
Daily alcohol consumption; past 3 months,%; 4.7%; 13.1%; 10.9%;
Alcohol dependence; past 12 months,%; 14.1%; 18.3%; 17.2%;
Unemployed,%; 48.4%; 22.3%; 29.3%;*
Employed/studying/housework,%; 43.8%; 68.6%; 61.9%;*
Have a partner,%; 26.6%; 46.9%; 41.4%;*
Considered suicide in the past month,%; 75.0%; 58.9%; 63.2%;*
  1. Abbreviations: BD = bipolar I disorder; CGI-BP-S = Clinical Global Impressions-Bipolar Version – Severity of Illness scale (range 1–7); EQ-5D = EuroQol instrument; HAMD21 = 21-item Hamilton Depression Rating scale; SAD = schizoaffective disorder; SD = standard deviation; YMRS = Young Mania Rating Scale. *Indicates statistical significance (p < 0.05) for comparison of BD and SAD participants. All p values are based on Fisher’s exact test except for HAMD21 and EQ-5D scores, which were tested using F-test analysis of variance.